10-K Decoder · All companies

Regeneron Pharmaceuticals, Inc.

REGN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$14.3B$14.2B+1.0%
Operating income$3.58B$3.99B−10.3%
Net income$4.50B$4.41B+2.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 30, 2026

$Q3 2026Year earlierChange
Revenue$5.12B$3.75B+36.3%
Operating income$2.05B$1.03B+99.5%
Net income$1.95B$1.46B+33.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Regeneron's revenue in FY2025?
$14.3B in FY2025 (Fiscal year ended Dec 31, 2025), +1.0% vs $14.2B a year earlier, per its 10-K filed Feb 2026.
Was Regeneron profitable in FY2025?
Yes: net income was $4.50B and operating income $3.58B in FY2025.
What was Regeneron's revenue in Q3 2026?
$5.12B (+36.3% vs a year earlier), per its Form 10-Q filed Oct 30, 2026.